Effectiveness of mRNA COVID-19 vaccines in preventing SARS-CoV-2 infections and COVID-19 hospitalisations and deaths in elderly long-term care facility residents, Spain, weeks 53 2020 to 13 2021Clara Mazagatos, Susana Monge, Carmen Olmedo et al.|Eurosurveillance|2021Cited by 84
Effectiveness of mRNA vaccine boosters against infection with the SARS-CoV-2 omicron (B.1.1.529) variant in Spain: a nationwide cohort studySusana Monge, Virgilio Yagüe Galaup, Antònia Galmés Truyols et al.|The Lancet Infectious Diseases|2022Cited by 84
Effectiveness of a Second Dose of an mRNA Vaccine Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Omicron Infection in Individuals Previously Infected by Other VariantsSusana Monge, Virgilio Yagüe Galaup, Ayelén Rojas‐Benedicto et al.|Clinical Infectious Diseases|2022Cited by 9
The Effectiveness of mRNA Vaccine Boosters for Laboratory-Confirmed COVID-19 During a Period of Predominance of the Omicron Variant of SARS-CoV-2Susana Monge, Miguel A. Hernán, Ayelén Rojas‐Benedicto et al.|SSRN Electronic Journal|2022Cited by 4
Análisis de la efectividad y el impacto de la vacunación frente a COVID-19 en residentes de centros de mayores en EspañaAurora Limia Sánchez, Elisa Martín‐Merino, Ma Carmen Olmedo Lucerón et al.|Unknown|2021Cited by 1